REGISTERED
on 08 Oct 2019
Last Applicant/ Owned by
100 BINNEY STREET, SUITE 710
CAMBRIDGE
MA
02142
Serial Number
86660168 filed on 11th Jun 2015
Registration Number
5880279 registered on 08th Oct 2019
Correspondent Address
Brandon P. Leahy
Filing Basis
1. intent to use
2. use application currently
Disclaimer
NO DATA
TRUC
Scientific research in the fields of pharmaceuticals, pharmaceutical research and development, laboratory testing, biotechnology, medicine, biologics, biotherapeutics, biosimilars, cancer treatment, oncology, and therapeutics, namely, polypeptide-based therapeutics, RNA-based therapeutics, and DNA-based therapeutics; providing information on the subject of scientific research in the fields of phar Read More
Classification Information
Class [042]
Computer & Software Services & Scientific Services
Scientific research in the fields of pharmaceuticals, pharmaceutical research and development, laboratory testing, biotechnology, medicine, biologics, biotherapeutics, biosimilars, cancer treatment, oncology, and therapeutics, namely, polypeptide-based therapeutics, RNA-based therapeutics, and DNA-based therapeutics; providing information on the subject of scientific research in the fields of pharmaceuticals, pharmaceutical research and development, laboratory testing, biotechnology, medicine, biologics, biotherapeutics, biosimilars, cancer treatment, oncology, and therapeutics, namely, polypeptide-based therapeutics, RNA-based therapeutics, and DNA-based therapeutics
First Use Date in General
30th Nov 2016
First Use Date in Commerce
30th Nov 2016
Class [005]
Pharmaceutical Products
Biotechnology and pharmaceutical products, namely, therapeutic cells, therapeutic proteins and therapeutic nucleic acids for human use for the treatment and prevention of cancer, inflammation and inflammatory diseases; pharmaceutical preparations for human use, namely, biotherapeutics, medicines, and therapeutics, namely, pharmaceutical polypeptides, pharmaceutical antibodies, pharmaceutical nucleic acids, polypeptide-based therapeutics, cell-based therapeutics, RNA-based therapeutics, and DNA-based therapeutics for the treatment and prevention of cancer, inflammation and inflammatory diseases
First Use Date in General
24th Jul 2019
First Use Date in Commerce
24th Jul 2019
Mark Details
Serial Number
No 86660168
Mark Type
No Service Mark
Attorney Docket Number
No 48538-TM1002
44D Filed
No
44D Current
No
44E filed
No
44E Current
No
66A Filed
No
66A Current
No
Current Basis
No
No Basis
No
Legal History
| Status Date | Action Taken |
|---|---|
| 08th Oct 2024 | COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED |
| 08th Oct 2019 | REGISTERED-PRINCIPAL REGISTER |
| 03rd Sep 2019 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
| 03rd Sep 2019 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
| 03rd Sep 2019 | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED |
| 02th Sep 2019 | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED |
| 05th Aug 2019 | STATEMENT OF USE PROCESSING COMPLETE |
| 01st Aug 2019 | TEAS STATEMENT OF USE RECEIVED |
| 01st Aug 2019 | USE AMENDMENT FILED |
| 06th Feb 2019 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |